Cellebrite DI Ratios (2020-2025) | CLBT

Ratios Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
Gross Margin (Quarter)
84.61%82.98%81.86%81.83%82.39%79.07%79.72%83.61%82.58%83.01%84.70%83.96%85.19%83.01%85.55%83.84%83.74%84.39%83.88%84.71%
EBT Margin (Quarter)
8.92%14.73%22.34%79.69%87.29%52.53%33.95%12.30%-54.24%-40.98%8.14%-13.27%-77.39%-23.00%-191.41%18.25%17.97%18.35%19.27%20.39%
EBIT Margin (Quarter)
8.23%13.89%4.69%6.34%-3.12%-8.95%-1.51%-10.25%0.19%6.03%16.01%16.13%10.32%13.05%18.20%14.42%11.41%12.73%15.07%16.15%
EBITDA Margin (Quarter)
5.00%12.69%12.07%2.14%87.59%50.52%35.34%11.06%-57.66%42.64%8.76%-15.04%79.18%25.13%194.58%19.20%15.07%18.74%15.88%16.32%
Operating Margin (Quarter)
8.23%13.89%4.69%6.34%-3.12%-8.95%-1.51%-10.25%0.19%6.03%16.01%16.13%10.32%13.05%18.20%14.42%11.41%12.73%15.07%16.15%
Net Margin (Quarter)
6.74%13.18%12.35%76.38%88.86%53.05%35.01%9.56%0.00%0.00%7.72%-15.75%0.00%0.00%-193.80%17.67%16.18%17.19%16.02%16.50%
FCF Margin (Quarter)
-0.54%24.36%-12.39%42.77%-17.10%-6.65%-0.89%50.17%19.01%22.69%35.95%49.55%12.88%17.33%40.68%63.41%21.59%31.95%29.04%70.46%
Efficiency
Inventory Average (Quarter)
5.66M7.18M7.99M8.73M9.76M10.79M11.11M11.02M10.57M9.60M9.02M9.25M9.33M8.95M9.25M9.09M8.13M
Assets Average (Quarter)
327.47M332.20M324.73M338.67M377.89M407.99M419.29M451.42M504.91M531.01M542.86M592.91M659.91M700.23M748.66M810.87M886.59M
Equity Average (Quarter)
-101.67M-42.78M5.92M41.76M66.66M56.61M28.46M27.75M36.08M3.75M-33.43M129.08M317.17M349.76M385.95M428.05M466.00M
Invested Capital (Quarter)
-129.98M-73.35M-12.22M24.06M59.46M73.86M39.36M17.56M37.94M34.21M-26.71M-40.16M298.32M336.02M363.49M408.41M447.69M484.32M
Asset Utilization Ratio (Quarter)
0.750.770.800.780.720.690.700.680.640.650.670.650.610.600.580.560.54
Leverage & Solvency
Equity Ratio (Quarter)
-0.41-0.22-0.040.070.170.180.100.040.080.06-0.05-0.070.470.490.510.520.540.52
Dividends & Payouts
FCF Payout Ratio (Quarter)
12.256.89
Valuation
Enterprise Value (Quarter)
-109.89M-145.97M-125.72M-91.69M-84.57M-132.29M-98.97M-110.50M-137.07M-228.21M-122.43M-106.96M-136.35M-345.40M-90.47M-179.22M-281.36M-285.51M
Return Ratios
Return on Sales (Quarter)
0.00%0.00%0.00%0.01%0.01%0.01%0.00%0.00%-0.01%0.00%0.00%0.00%-0.01%0.00%-0.02%0.00%0.00%0.00%0.00%0.00%
Return on Capital Employed (Quarter)
14.20%8.46%-0.10%-2.90%-9.53%-6.95%-1.82%4.74%13.24%14.29%16.43%17.56%15.62%14.53%14.10%12.43%12.86%
Return on Invested Capital (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.01%0.12%-0.02%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Assets (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%0.00%0.00%0.00%0.00%0.00%
Return on Equity (Quarter)
-0.01%-0.03%0.25%0.04%0.02%0.00%-0.01%-0.02%-0.02%-0.30%0.03%-0.02%-0.01%-0.01%0.00%0.00%0.00%